A Liquid Chromatography-Quadrupole-Time-Of-Flight Mass Spectrometric Assay for the Quantification of Fabry Disease Biomarker Globotriaosylceramide (GB3) in Fabry Model Mouse

Pharmaceutics - Switzerland
doi 10.3390/pharmaceutics10020069

Related search